Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Tipo de estudo
Intervalo de ano
1.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2014; 24 (4): 285-287
em Inglês | IMEMR | ID: emr-142092

RESUMO

Congenital amegakaryocytic thrombocytopenia [CAMT] is a rare, autosomal recessive disorder induced by mutations of the gene coding for thrombopoietin [TPO] receptor [c-MPL] despite high levels of serum TPO. Patients initially present with isolated thrombocytopenia that subsequently progresses into pancytopenia. Although the mechanisms leading to aplasia are unknown, the age of onset has been reported to depend on the severity of the c-MPL functional defect. The primary treatment for CAMT is bone marrow transplantation. This report describes a newborn girl who presented to us with symptoms of sepsis but septic profile came negative except thrombocytopenia. Bone marrow biopsy was done for thrombocytopenia which revealed amegakaryocytic thrombocytopenia. She was given prednisolone.


Assuntos
Humanos , Feminino , Mutação , Receptores de Trombopoetina , Pancitopenia , Transplante de Medula Óssea
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA